Company SD BioSensor, Inc

Equities

A137310

KR7137310009

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for SD BioSensor, Inc

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
10,540 ^KRW	+0.48%		+4.46%	-7.87%

2023	SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc.	CI
2023	SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc.	CI

SD Biosensor Inc is a Korea-based company mainly engaged in the development and sale of in vitro diagnostics. The Company is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The Company is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 576

KRW in Million	2022	Weight	2023	Weight	Delta
Other Products 41.8 %	-	-	273,968	41.8 %	-
Immunochemical Diagnosis 24.2 %	-	-	158,798	24.2 %	-
Other (Goods, Services, Etc.) 20.4 %	7,739	0.3 %	134,003	20.4 %	+1,631.53%
Self-monitoring of Blood Sugar Level 9.3 %	-	-	61,107	9.3 %	-
Molecular Diagnostics 4.2 %	-	-	27,801	4.2 %	-

KRW in Million	2022	Weight	2023	Weight	Delta
America 38.6 %	385,087	13.1 %	252,820	38.6 %	-34.35%
Europe 29.8 %	1,698,767	57.9 %	195,600	29.8 %	-88.49%
Asia 13.7 %	358,563	12.2 %	89,722	13.7 %	-74.98%
South Korea 11.3 %	431,064	14.7 %	73,968	11.3 %	-82.84%
India 4.9 %	44,986	1.5 %	31,828	4.9 %	-29.25%
Africa 1.8 %	13,533	0.5 %	11,739	1.8 %	-13.26%

Managers	Title	Age	Since
Tae-Yeong Heo CEO	Chief Executive Officer	55	-
Hyo-Geun Lee CEO	Chief Executive Officer	60	-
Chul-Kyu Oh DFI	Director of Finance/CFO	53	-
Eun-Hye Lee CMP	Compliance Officer	45	-
Hye-Im Cho SAM	Sales & Marketing	37	-

Members of the board	Title	Age	Since
Hyo-Geun Lee CEO	Chief Executive Officer	60	-
Young-Sik Cho CHM	Chairman	62	-
Sang-Kyun Cha BRD	Director/Board Member	66	23-08-31
Byung-Soo Yoon BRD	Director/Board Member	-	-
Seong-Hwan Choi BRD	Director/Board Member	53	-
Tae-Yeong Heo CEO	Chief Executive Officer	55	-
Byung-Chul Kim BRD	Director/Board Member	63	-
Woo-Chang Lee BRD	Director/Board Member	53	22-03-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	124,477,353	35,109,229 ( 28.21 %)	2,129,887 ( 1.711 %)	28.21 %

Name	Equities	%	Valuation
Young-Sik Cho 65.23 %	81,198,713	65.23 %	712 M ₩
Hyo-Geun Lee 3.376 %	4,201,989	3.376 %	37 M ₩
SD BIOSENSOR, INC 1.711 %	2,129,887	1.711 %	19 M ₩
Tae-Yeong Heo 0.3189 %	396,935	0.3189 %	3 M ₩
Geun-gook Son 0.2764 %	344,000	0.2764 %	3 M ₩
Jae-young Hwang 0.1771 %	220,500	0.1771 %	2 M ₩
Seong-Jin Park 0.1729 %	215,200	0.1729 %	2 M ₩
Hyung-gil Choi 0.1722 %	214,342	0.1722 %	2 M ₩
Byung-Ki Cho 0.1205 %	150,000	0.1205 %	1 M ₩
Hye-Im Cho 0.1013 %	126,135	0.1013 %	1 M ₩

Name	Equities	%	Valuation
SD BIOSENSOR, INC 1.71%	2,129,887	1.71%	18,668,651 $

SD Biosensor, Inc.

4-5, Digital Empire Building C 16 Deogyeong-daero 1556beon-gil

16690, Suwon-si

http://sdbiosensor.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

10,540 KRW

Average target price

10,000 KRW

Spread / Average Target

-5.12%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
SD BIOSENSOR, INC	-7.87%	952M
BIOMÉRIEUX	-1.89%	12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.68B
DIASORIN S.P.A.	-1.31%	5.29B
LANTHEUS HOLDINGS, INC.	+21.82%	5.18B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-50.89%	3.29B
ANDON HEALTH CO., LTD.	+6.42%	2.6B
VITROLIFE AB	-10.02%	2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B

Diagnostic & Testing Substances